Document is current
Any future updates will be listed below
-
Authors
Gaudio, Hunter A. https://orcid.org/0000-0002-3104-8467
Bliss, Andrew https://orcid.org/0009-0008-1811-3878
Loy, Conor J.
Eweis-LaBolle, Daniel https://orcid.org/0000-0001-7599-6082
Gardella, Anne E. https://orcid.org/0000-0003-1860-8316
De Vlaminck, Iwijn https://orcid.org/0000-0001-6085-7311
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (R01AI151059)
U.S. Department of Health & Human Services | National Institutes of Health (R21AI173979)
U.S. Department of Health & Human Services | National Institutes of Health (R01AI146165)
U.S. Department of Health & Human Services | National Institutes of Health (R01AI192977)
- License Information
-
More Information
Article History
Received: 20 August 2025
Accepted: 28 May 2026
First Online: 11 June 2026
Competing interests
: I.D.V. is listed as an inventor on submitted patents pertaining to cell-free nucleic acids (US patent applications 63/237,367, 63/429,733, 63/056,249, 63/015,095, 16/500,929, 41614P-10551-01-US). I.D.V. is a member of the Scientific Advisory Board of Karius Inc. and a co-founder and advisor for Kanvas Biosciences and Romix Biosciences. C.J.L. is the CEO and co-founder of Romix Biosciences. The remaining authors declare no competing interests.
